CD44 and neoplasm: However, some studies indicate an association of CD44v with the luminal A subtype of breast cancer, which generally has a better prognosis [69], while the CD44 variant v3–10 has shown superior effectiveness compared to the standard isoform in slowing tumor growth and metastasis [71].